{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:22:02Z","timestamp":1787772122710,"version":"build-2784847793"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:p>Diffuse large B-cell lymphoma is the most prevalent form of non-Hodgkin\u2019s lymphoma that is usually treated with chemoimmunotherapy. If the disease proves refractory or recurrent, the primary treatment approach involves high-dose chemotherapy with bone marrow transplantation. The collection of peripheral blood stem cells before transplantation plays a vital role in the treatment process, necessitating the mobilization of blood stem cells from the bone marrow to the peripheral blood. Despite using standard methods such as granulocyte colony-stimulating factor (G-CSF), chemotherapy, and plerixafor, some patients cannot collect an optimal count of CD34+ cells for transplantation. Managing these patients with poor mobilization poses significant challenges. In this article, we present a case of a poor mobilizer patient who achieved prosperous mobilization by using recombinant human G-CSF, recombinant human growth hormone, and plerixafor.<\/jats:p>","DOI":"10.4103\/jrpp.jrpp_46_23","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T11:54:48Z","timestamp":1714478088000},"page":"110-113","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Successful Stem Cell Mobilization and CD34+ Cell Collection in a Poor Mobilizer: A Case Report Utilizing a Combination of Recombinant Growth Colony Stimulating Factor, Recombinant Human Growth Factor, and Plerixafor"],"prefix":"10.4103","volume":"12","author":[{"given":"Maliheh Kazemi","family":"Najafabadi","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy and Pharmacy Practice, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azadeh","family":"Moghaddas","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy and Pharmacy Practice, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mozhgan","family":"Karimifar","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Darakhshandeh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,4,30]]},"reference":[{"key":"R1-20240907","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pathol.2017.09.006","article-title":"Diffuse large B-cell lymphoma","volume":"50","author":"Li","year":"2018","journal-title":"Pathology"},{"key":"R2-20240907","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1182\/blood-2010-03-276246","article-title":"Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: A study by the Groupe d\u2019Etudes des Lymphomes de l\u2019Adulte","volume":"116","author":"Coiffier","year":"2010","journal-title":"Blood"},{"key":"R3-20240907","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.bbmt.2011.10.010","article-title":"High-dose therapy and autologous stem cell transplantation in first relapse for diffuse large B cell lymphoma in the rituximab era: An analysis based on data from the European blood and marrow transplantation registry","volume":"18","author":"Mounier","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"R4-20240907","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/bmt.2009.130","article-title":"Safety and efficacy assessment of plerixafor in patients with multiple myeloma proven or predicted to be poor mobilizers, including assessment of tumor cell mobilization","volume":"45","author":"Tricot","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"R5-20240907","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/bmt.2008.410","article-title":"Improving stem cell mobilization strategies: Future directions","volume":"43","author":"Bensinger","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"R6-20240907","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1365-2141.2010.08313.x","article-title":"Current status of stem cell mobilization","volume":"150","author":"Gertz","year":"2010","journal-title":"Br J Haematol"},{"key":"R7-20240907","first-page":"11","article-title":"Increased mobilization and yield of stem cells using plerixafor in combination with granulocyte-colony stimulating factor for the treatment of non-Hodgkin\u2019s lymphoma and multiple myeloma","volume":"4","author":"Pelus","year":"2011","journal-title":"Stem Cells Cloning"},{"key":"R8-20240907","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1172\/JCI113385","article-title":"Enhancement of human granulopoiesis in vitro by biosynthetic insulin-like growth factor I\/somatomedin C and human growth hormone","volume":"81","author":"Merchav","year":"1988","journal-title":"J Clin Invest"},{"key":"R9-20240907","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1182\/blood-2003-07-2428","article-title":"Use of recombinant human growth hormone (rhGH) plus recombinant human granulocyte colony-stimulating factor (rhG-CSF) for the mobilization and collection of CD34+ cells in poor mobilizers","volume":"103","author":"Carlo-Stella","year":"2004","journal-title":"Blood"},{"key":"R10-20240907","doi-asserted-by":"crossref","first-page":"4530","DOI":"10.1182\/blood-2011-06-318220","article-title":"How I treat patients who mobilize hematopoietic stem cells poorly","volume":"118","author":"To","year":"2011","journal-title":"Blood"},{"key":"R11-20240907","doi-asserted-by":"crossref","first-page":"e2012066","DOI":"10.4084\/mjhid.2012.066","article-title":"New strategies for stem cell mobilization","volume":"4","author":"Lemoli","year":"2012","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"R12-20240907","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/jca.21551","article-title":"Impact of plerixafor (mozobil) on hospital efficiency: A single center experience","volume":"33","author":"Azar","year":"2018","journal-title":"J Clin Apher"},{"key":"R13-20240907","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1515\/JPEM.1998.11.6.677","article-title":"The haematopoietic effects of growth hormone and insulin-like growth factor-I","volume":"11","author":"Merchav","year":"1998","journal-title":"J Pediatr Endocrinol Metab"},{"key":"R14-20240907","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fendo.2013.00064","article-title":"Adult growth hormone deficiency \u2013 Benefits, side effects, and risks of growth hormone replacement","volume":"4","author":"Reed","year":"2013","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Journal of Research in Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jrpp.jrpp_46_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:30:00Z","timestamp":1787769000000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jrpp.jrpp_46_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/jrpp.jrpp_46_23","relation":{},"ISSN":["2319-9644","2279-042X"],"issn-type":[{"value":"2319-9644","type":"print"},{"value":"2279-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"2023-04-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}